Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review. [electronic resource]
Producer: 20110203Description: 887-94 p. digitalISSN:- 1573-0646
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Ascites -- drug therapy
- Bevacizumab
- Fatal Outcome
- Female
- Humans
- Injections, Intraperitoneal
- Interferon-gamma -- biosynthesis
- Lymphocyte Subsets -- immunology
- Middle Aged
- Ovarian Neoplasms -- complications
- Pilot Projects
- Randomized Controlled Trials as Topic
- Recurrence
- Remission Induction
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.